Biorasi Clinical Research Case Studies
The Biorasi Project Team were focused on the completion of two critical project milestones which were suddenly put at risk due to the COVID-19 health crisis. Find out how the team were able to keep the project on track in our latest case study.
The Biorasi Project Team were focused on the completion of two critical project milestones which were suddenly put at risk due to the COVID-19 health crisis. Find out how the team were able to keep the project on track in our latest case study.
IBM is the leading healthcare technology organization in the world. Recently, they wrote a case study on how Biorasi was able to remove the obstacles and optimize its efforts in running clinical trials.
Global studies are notoriously complicated with language barriers, time zone differences, and oft-contradictory regulations. These business challenges are exacerbated, not only working with multiple, but unique cultures. Biorasi encountered this scenario when we were brought in to rescue a complex clinical trial being run in the US and Japan.
Site selection is one of the most crucial parts of planning a study. Ensuring that sites are performing up to par while a trial is underway is equally important but often neglected. Biorasi was asked to assist in a phase II trial of stem cell therapy for traumatic brain injury (TBI).
Patient compliance was a serious concern, particularly regarding the reduction of sun exposure. Running a dermatology trial, especially in the middle of summer, can greatly affect patient compliance and the resulting, potential flare-ups in any dermatological condition.
Intelligent Project Management to the Rescue of a Scabies Generic Trial
Strict Processes Rescue Complex MS Trial: Biorasi’s Project Management-first Approach Allows Rapid Feasibility and Site Startup to Meet Critical Deadlines
A Modern Approach to Patient Education Increases Enrollment
Not every study presents a completely new and unique set of challenges. That’s not to say that the trial is generic, or not complex, but rather that Biorasi’s past work covers a large breadth and depth of experience. That experience allows us to see a lot of potential trial-stopping issues before they happen, and account for them in our planning. When we were asked to complete a trial on an acute lower back pain medication, we needed to identify potential pitfalls early in the planning process to make sure they wouldn’t lead to surprises later.
Flexibility and Strong Process-driven Planning Overcomes Regulatory Speed-bumps
CNS trials especially can become mired down and derailed by a too-low enrollment rate, and the culprit is usually poor venue and site planning and selection. Patient Enrollment Needs To Be Strategic, Not Just Tactical. Learn more in this case study
